These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33382099)
1. A randomized, double-dummy, emergency department-based study of greater occipital nerve block with bupivacaine versus intravenous metoclopramide for treatment of migraine: A comment. Oswald JC; Schuster NM Headache; 2021 Jan; 61(1):218. PubMed ID: 33382099 [No Abstract] [Full Text] [Related]
2. A Randomized, Double-Dummy, Emergency Department-Based Study of Greater Occipital Nerve Block With Bupivacaine vs Intravenous Metoclopramide for Treatment of Migraine. Friedman BW; Irizarry E; Williams A; Solorzano C; Zias E; Robbins MS; Harrilal MA; Del Valle M; Bijur PE; Gallagher EJ Headache; 2020 Nov; 60(10):2380-2388. PubMed ID: 32981043 [TBL] [Abstract][Full Text] [Related]
3. A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide. Friedman BW; Mohamed S; Robbins MS; Irizarry E; Tarsia V; Pearlman S; John Gallagher E Headache; 2018 Oct; 58(9):1427-1434. PubMed ID: 30144034 [TBL] [Abstract][Full Text] [Related]
4. The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments. Korucu O; Dagar S; Çorbacioglu ŞK; Emektar E; Cevik Y Acta Neurol Scand; 2018 Sep; 138(3):212-218. PubMed ID: 29744871 [TBL] [Abstract][Full Text] [Related]
5. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study. Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035 [TBL] [Abstract][Full Text] [Related]
6. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study. Inan LE; Inan N; Karadaş Ö; Gül HL; Erdemoğlu AK; Türkel Y; Akyol A Acta Neurol Scand; 2015 Oct; 132(4):270-7. PubMed ID: 25765043 [TBL] [Abstract][Full Text] [Related]
7. Comment on a Randomized Controlled Trial of Intravenous Haloperidol versus Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department. Fisher H J Emerg Med; 2017 Mar; 52(3):e75. PubMed ID: 27856026 [No Abstract] [Full Text] [Related]
8. What Is the Optimal Placebo for Clinical Trials of Nerve Blocks in Headache?: An N-of-1 Study of Lactated Ringer's. Smith JH; Potter JL; Robblee JV Headache; 2019 Jan; 59(1):108-109. PubMed ID: 30575969 [No Abstract] [Full Text] [Related]
9. Intravenous metoclopramide versus dexketoprofen trometamol versus metoclopramide+ dexketoprofen trometamol in acute migraine attack in the emergency department: A randomized double-blind controlled trial. Yavuz E; Gulacti U; Lok U; Turgut K Am J Emerg Med; 2020 Nov; 38(11):2254-2258. PubMed ID: 32359776 [TBL] [Abstract][Full Text] [Related]
10. Greater occipital nevre block in migraine headache: preliminary results of 10 patients. Takmaz SA; Inan N; Uçler S; Yazar MA; Inan L; Başar H Agri; 2008 Jan; 20(1):47-50. PubMed ID: 18338279 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of the greater occipital nerve block in recurrent migraine type headaches. Okmen K; Dagistan Y; Dagistan E; Kaplan N; Cancan E Neurol Neurochir Pol; 2016; 50(3):151-4. PubMed ID: 27154440 [TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Corbo J; Esses D; Bijur PE; Iannaccone R; Gallagher EJ Ann Emerg Med; 2001 Dec; 38(6):621-7. PubMed ID: 11719739 [TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department. Gaffigan ME; Bruner DI; Wason C; Pritchard A; Frumkin K J Emerg Med; 2015 Sep; 49(3):326-34. PubMed ID: 26048068 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Occipital Nerve Blocks for Acute Pain Relief of Migraines. Ebied AM; Nguyen DT; Dang T J Clin Pharmacol; 2020 Mar; 60(3):378-383. PubMed ID: 31595507 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the clinical efficacy of GON block at the C2 level and GON block at the classical distal occipital level in the treatment of migraine. Karaoğlan M; İnan LE Clin Neurol Neurosurg; 2022 Apr; 215():107190. PubMed ID: 35286995 [TBL] [Abstract][Full Text] [Related]
17. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial. Friedman BW; Cabral L; Adewunmi V; Solorzano C; Esses D; Bijur PE; Gallagher EJ Ann Emerg Med; 2016 Jan; 67(1):32-39.e3. PubMed ID: 26320523 [TBL] [Abstract][Full Text] [Related]
18. Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. Griffith JD; Mycyk MB; Kyriacou DN J Pain; 2008 Jan; 9(1):88-94. PubMed ID: 17981511 [TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Coppola M; Yealy DM; Leibold RA Ann Emerg Med; 1995 Nov; 26(5):541-6. PubMed ID: 7486359 [TBL] [Abstract][Full Text] [Related]
20. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Tek DS; McClellan DS; Olshaker JS; Allen CL; Arthur DC Ann Emerg Med; 1990 Oct; 19(10):1083-7. PubMed ID: 2221512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]